Global Expression Vectors Market Set for Moderate Growth to Reach USD around 330.3 Million by 2028

The rising need for protein-based treatments (biologics), the high frequency of lifestyle diseases, infectious diseases, and genetic disorders, and increased financing for protein research are all contributing to the market’s rise. High market consolidation, which raises entry barriers, and the high cost of protein treatment, on the other hand, are the key issues limiting the industry’s growth.

The expression vectors market is predicted to increase at a CAGR of 5.5 percent from 2015 to 2020, reaching $317.1 million from $242.7 million in 2015.

North America dominates this market, with the United States accounting for a significant portion of the total. The Asian market, on the other hand, is expected to increase at the fastest rate throughout the projection period. Factors such as significant growth in the pharmaceutical and biotechnology sectors, the presence of key market players in the area, and changing legislative frameworks to promote innovation and commercialization will drive expansion in the Asian market.

Thermo Fisher Scientific, Inc. (United States), Promega Corporation (United States), Sigma-Aldrich Corporation (United States), Agilent Technologies (United States), Bio-Rad Laboratories (United States), New England Biolabs (United States), Merck Millipore (United States), QIAGEN (Netherlands), Clontech Laboratories, Inc. (United States), DNA2.0 (Uni (U.S.).
The Report’s Scope

Global Expression Vectors Market
Global Expression Vectors Market

The market is segmented by host type, application, end user, and region in this study.

Type of Host

Expression Vectors for Bacteria

Expression Vectors for E. Coli

Bacterial Expression Vectors (Other Bacterial Expression Vectors)

Expression Vectors for Mammalian Organisms

Expression Vectors for CHO

Other Expression Vectors for Mammalian Organisms

Vectors for Insect Expression

Expression Vectors for Baculoviruses

Other Vectors for Insect Expression

Expression Vectors for Yeast

Expression Vectors from K. Lactis

Expression Vectors for Pichia Pastoris

Expression Vectors for Saccharomyces Cerevisiae

Other Expression Vectors for Yeast

Additional Expression Vectors

by way of application

Applications in Medicine

Applications of Research

Applications in Industry

By the End User

Biotechnology and pharmaceutical companies

Contract Research Organizations (CROs) and Contract Manufacturing Organizations (CMOs) are two types of contract research organisations (CMOs)

Institutes of Academic Research

End Users from Other Industries

Region by Region

North America is located in North America.

U.S.

Canada

Europe

Asia

The World at Large (RoW)

A plasmid or virus utilised for protein expression in many types of host cells is known as an expression vector/expression construct. An expression vector assists in the introduction of a gene of interest into a target cell and activates the cell’s mechanism to manufacture the gene’s protein. This is a slow-growing market, with demand for protein-based medications (biologics) increasing, as well as the high frequency of lifestyle diseases, infectious diseases, and genetic abnormalities, as well as increased financing for protein research and protein treatment. High market consolidation, which raises entry barriers, and the high cost of protein treatment, on the other hand, are the key issues limiting the industry’s growth. High development potential in emerging economies, on the other hand, presents fresh growth chances for market participants.

The expression vectors market is predicted to increase at a CAGR of 5.5 percent from 2015 to 2020, reaching $317.1 million from $242.7 million in 2015. This market is divided into host type, application, end user, and region segments.

This market is divided into bacterial, mammalian, insect, yeast, and other expression vectors based on host type. E. Coli expression vectors and other bacterial expression vectors are separated from bacterial expression vectors. The market for mammalian expression vectors is further divided into CHO expression vectors and other mammalian expression vectors. The insect expression vectors market is divided into two categories: Baculovirus expression vectors and other insect expression vectors. Expression vectors for K. lactis systems, Pichia pastoris systems, Saccharomyces cerevisiae systems, and other yeast systems make up the yeast expression vectors market.

This global market is divided into therapeutic, research, and industrial applications based on application. Pharmaceutical and biotechnology firms, contract research organisations (CROs) and contract manufacturing organisations (CMOs), academic research institutes, and other end users are the market’s end users.

Annual Reports, SEC Filings, Investor Presentations, World Bank, World Intellectual Property Organization, Industry Canada, International Federation of Pharmaceutical Manufacturers & Associations, Centre for Drug Research (CDR), President’s Council of Advisors on Science and Technology, Nature Biotechnology Journal on Next-Generation Protein Drugs, Human Proteome Organization, Expert Interviews, and MarketsandMarkets Analysis are all sources.

North America leads the global market, followed by Europe, Asia, and the Rest of the World (RoW). During the projection period, North America will continue to lead the market. Asia, on the other hand, is expected to develop at the fastest rate during the predicted period. Growth in Asia is expected to be centred on China and India over the next five years.

Thermo Fisher Scientific, Inc. (United States), Promega Corporation (United States), Sigma-Aldrich Corporation (United States), Agilent Technologies (United States), Bio-Rad Laboratories (United States), New England Biolabs (United States), Merck Millipore (United States), QIAGEN (Netherlands), Clontech Laboratories, Inc. (United States), DNA2.0 (Uni (U.S.).

Sagar is a Digital Marketing Associate in a Leading Market Research Company. He has a very deep interest in all technology topics whatsoever. His passion, dedication and quick decision-making ability make him stand apart from others. He has involvement in both B2C and B2B markets.

Leave a Reply

Your email address will not be published.